Effects of different B-cell-depleting strategies on the lymphatic tissue
1. 系统已在2025-07-22 14:20:34对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接: https://pubmed.ncbi.nlm.nih.gov/40651933/
其他信息:
C Tur, M Eckstein, L Bucci, J Auth, C Bergmann…
Annals of the Rheumatic …, 2025
Elsevier
Objectives To assess the efficacy of new protein-based B cell depletion with glyco-engineered anti-CD20 antibody obinutuzumab (OBI) and the CD19/CD3 T cell engager blinatumomab (BLI) in patients with autoimmune diseases (AIDs) in comparison to rituximab (RTX) and CD19 chimeric antigen receptor (CAR) T cell therapy. Methods Sequential inguinal lymph node biopsies were taken before and after treatment with OBI-, BLI-, RTX-and CD19-CAR T cells in patients with AID. CD19 and CD20 B cells, plasma cells, T cells …
